HUTCHMED (China) (HCM) Retained Earnings (2015 - 2026)
HUTCHMED (China) (HCM) posted quarterly Retained Earnings of -$3.2 million for Q2 2026, up 42.04% year-over-year from -$2.2 million in Q2 2025, and up 29.79% quarter-over-quarter from -$4.5 million in Q4 2025.
HUTCHMED (China) (HCM) Retained Earnings (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Retained Earnings for 12 consecutive years, with -$3.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Retained Earnings rose 42.04% year-over-year to -$3.2 million; the TTM figure through Jun 2026 stood at -$3.2 million (up 42.04% YoY), while the FY2025 annual figure was -$4.5 million, changed N/A from the prior year.
- Retained Earnings improved to -$3.2 million in Q2 2026 per HCM's latest filing, from -$4.5 million in the prior quarter.
- Across five years, Retained Earnings topped out at $1.5 billion in Q2 2022 and bottomed at -$971.5 million in Q4 2022.
- Historically, Retained Earnings has averaged -$48.5 million across 5 years, with a median of -$6.6 million in 2023.
- Annual changes were most pronounced in 2022 — Retained Earnings slumped 164.54% — and 2025, when it soared 42.42%.
- HUTCHMED (China)'s Retained Earnings stood at -$971.5 million in 2022, then increased by 10.36% to -$870.9 million in 2023, then surged by 98.91% to -$9.5 million in 2024, then surged by 52.46% to -$4.5 million in 2025, then grew by 29.79% to -$3.2 million in 2026.
- Business Quant data shows HCM's Retained Earnings at -$3.2 million in Q2 2026, -$4.5 million in Q4 2025, and -$5.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.43 Bn | 43.46 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.68 Bn | 40.02 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.49 Bn | 30.82 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.09 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 19.03 Bn | 18.14 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.03 Bn | 11.50 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | HUTCHMED (China) | 2.19 Bn | 2.19 Bn | - | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.18 Mn |
| Dec 31, 2025 | -4.53 Mn |
| Jun 30, 2025 | -5.49 Mn |
| Jun 30, 2024 | -9.53 Mn |
| Dec 31, 2023 | -870.87 Mn |
| Jun 30, 2023 | -7.80 Mn |
| Dec 31, 2022 | -971.48 Mn |
| Jun 30, 2022 | 1.48 Bn |
| Dec 31, 2021 | 1.51 Bn |
| Jun 30, 2021 | 1.41 Bn |
| Mar 31, 2021 | 808.78 Mn |
| Dec 31, 2020 | 822.46 Mn |
| Jun 30, 2020 | -5.53 Mn |
| Dec 31, 2019 | 514.90 Mn |
| Sep 30, 2019 | -5.58 Mn |
| Jun 30, 2019 | -400,000.00 |
| Mar 31, 2019 | 508.55 Mn |
| Dec 31, 2018 | 243,000.00 |
| Jun 30, 2018 | 497.52 Mn |
| Dec 31, 2017 | 496.96 Mn |